Page last updated: 2024-08-22

titanium dioxide and imatinib mesylate

titanium dioxide has been researched along with imatinib mesylate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Feng, YQ; Li, X; Liu, J; Lü, S; Luo, Q; Wang, F; Wu, J; Xiong, S1
Do, B; Karoui, M; Levi, Y; Sadou Yayé, H; Secrétan, PH; Solgadi, A; Tortolano, L; Yagoubi, N1
Choi, HG; Gautam, M; Gupta, B; Jeong, JH; Kim, JO; Ku, SK; Maharjan, S; Poudel, K; Soe, ZC; Yong, CS1
Bhullar, S; Goyal, N; Gupta, S1

Other Studies

4 other study(ies) available for titanium dioxide and imatinib mesylate

ArticleYear
Inhibitor screening of protein kinases using MALDI-TOF MS combined with separation and enrichment of phosphopeptides by TiO2 nanoparticle deposited capillary column.
    The Analyst, 2010, Volume: 135, Issue:11

    Topics: Antineoplastic Agents; Benzamides; Chronic Disease; Drug Screening Assays, Antitumor; Humans; Imatinib Mesylate; Leukemia, Myeloid; Nanoparticles; Phosphopeptides; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium

2010
Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products.
    The Science of the total environment, 2019, Mar-10, Volume: 655

    Topics: Adsorption; Aliivibrio fischeri; Aquatic Organisms; Biodegradation, Environmental; Catalysis; Computer Simulation; Endocrine Disruptors; Imatinib Mesylate; Molecular Structure; Mutagens; Photolysis; Quantitative Structure-Activity Relationship; Titanium; Water Pollutants, Chemical

2019
Stealth Polymer-Coated Graphene Oxide Decorated Mesoporous Titania Nanoplatforms for In Vivo Chemo-Photodynamic Cancer Therapy.
    Pharmaceutical research, 2020, Aug-04, Volume: 37, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; HCT116 Cells; HT29 Cells; Humans; Imatinib Mesylate; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Reactive Oxygen Species; Silicon Dioxide; Titanium

2020
In-vitro pH-responsive release of imatinib from iron-supplement coated anatase TiO
    Scientific reports, 2022, 03-17, Volume: 12, Issue:1

    Topics: Humans; Hydrogen-Ion Concentration; Imatinib Mesylate; Iron; Metal Nanoparticles; Nanoparticles; Titanium

2022